Evidence map›Paper›PMID 35585659›Full record

ArticleEuropean journal of haematology2022

Development and validation of the sickle cell stress scale-adult.

Wally R Smith, Donna K McClish, Viktor E Bovbjerg, Harjot K Singh

Abstract read
In one paragraph

Article in European journal of haematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wally R SmithSection of Research, Division of General Internal Medicine, Virginia Commonwealth University, Richmond, Virginia, USA.ORCID https://orcid.org/0000-0002-4122-5367
Donna K McClishDepartment of Biostatistics, Virginia Commonwealth University, Richmond, Virginia, USA.ORCID https://orcid.org/0000-0003-0344-6377
Viktor E BovbjergCollege of Health and Human Sciences, Oregon State University, Corvallis, Oregon, USA.ORCID https://orcid.org/0000-0003-3244-9067
Harjot K SinghDivision of Infectious Diseases, Weill Cornell Medicine, New York, New York, USA.ORCID https://orcid.org/0000-0001-5296-9583

Funding

Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient NavigatorsR18HL112737 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI SMITH, WALLY R · 2012 to 2017
$3.3M
PAIN IN SICKLE CELL EPIDEMIOLOGIC STUDYR01HL064122 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI SMITH, WALLY R · 2001 to 2003
$2.2M
Virginia Comprehensive Sickle Cell Center-Center: Basic & Translational ResearchU54HL090516 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI SMITH, WALLY R · 2008 to 2011
$1.4M
Virginia Commonwealth University Sickle Cell Disease Clinical NetworkU10HL083732 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI SMITH, WALLY R · 2006 to 2008
$904k
A.D. Williams Faculty Research Grant, Virginia Commonwealth UniversityA.D. Williams Student Research Fellowships, Virgin ia Commonwealth UniversityClinical Research Training Program, National Institutes of HealthEnhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient NavigatorsEnhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators (NCT02197845, 1 R18 HL 112737, National Heart, Lung, and Blood InstituteNHLBI NIH HHS R01 HL064122NHLBI NIH HHS R18 HL112737NHLBI NIH HHS U10 HL083732NHLBI NIH HHS U54 HL090516Pain in Sickle Cell Epidemiology Study, 1 R01 HL 64122, National Heart, Lung, and Blood InstituteRobert Wood Johnson Foundation Generalist Physician Faculty Scholar Award (1993-1997)Sickle Cell Disease Clinical Research Network, National Heart, Lung, and Blood Institute 1U10HL083732VCU School of Medicine Student FellowshipsVirginia Basic and Translational Research Program in Sickle Cell Disease. 1U54HL090516, National Heart, Lung, and Blood Institute
6 · The paper itself

Abstract

Disease-specific stress can partly explain Sickle Cell Disease (SCD) healthcare utilization. We developed and validated two measures of adult SCD-specific stress for research and clinical care. A large cohort of adults with SCD completed both the 3-item Likert-scale adapted from a previous disease stress measure and a 10-item Likert-scale questionnaire drafted specifically to measure SCD stress. They concurrently completed a psychosocial and health-related quality of life scale battery, then subsequently daily pain diaries. Diaires measured: daily intensity, distress and interference of pain; self-defined vaso-occlusive crises (VOC), opioid use, and types of healthcare utilization for up to 24 weeks. Analyses tested Cronbach's alpha, correlation of the three-item and 10-item stress scales with the concurrent battery, with percentages of pain days, VOC days, opioid use days, and healthcare utilization days, and correlation of baseline stress and 6-month stress for the 10-item scale. Cronbach's alpha was high for both the 3-item (0.73) and 10-item (0.83) SCD stress scales, test-retest correlation of 0.55, expected correlation with the concurrent battery, and correlation with diary-measured healthcare utilization over 6 months. The correlations with the 3-item scale were stronger, but only statistically significant for depression-anxiety. The correlation between the two stress scales was 0.59. Both the 3-item and the 10-item stress scales exhibited good face, construct, concurrent, and predictive validity as well as moderate test-retest reliability. Further scale validation should determine population norms and response to interventions.

Indexed as

Anemia, Sickle CellVolatile Organic CompoundsAdultAnalgesics, OpioidHumansPainPsychometricsQuality of LifeReproducibility of ResultsSurveys and QuestionnairesAnalgesics, OpioidVolatile Organic Compoundsassessmentcopinghealthcare utilizationpainsickle cell diseasestress

Identifiers

PMID35585659
PMCPMC9531901

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.